Eeva Piitulainen
21 – 30 of 85
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
European Respiratory Society statement : Diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency
- Contribution to journal › Article
- 2016
-
Mark
Recovery of inhaled nanoparticles, airflow obstruction and emphysema
(2016) European Respiratory Society (ERS) Congress 2016
- Contribution to conference › Abstract
-
Mark
Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden
- Contribution to journal › Article
-
Mark
Vital capacity and COPD : The Swedish CArdioPulmonary bioImage Study (SCAPIS)
- Contribution to journal › Article
- 2015
-
Mark
Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.
- Contribution to journal › Article
-
Mark
The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.
- Contribution to journal › Article
-
Mark
Chronic Obstructive Pulmonary Disease Is Common in Never-smoking Patients with Primary Sjögren Syndrome.
- Contribution to journal › Article
-
Mark
Relationship between Change in Lung Density and Long-Term Progression of Lung Function.
- Contribution to journal › Letter
-
Mark
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
- Contribution to journal › Article
-
Mark
Using nanoparticles to detect emphysema
(2015) European respiratory society international congress 2015
- Contribution to conference › Abstract
